The potential of this study to provide proof-of-concept (PoC) for the use of CT-996 in the treatment of obesity at Phase 1 is limited, given that Phase 1 studies are primarily designed to assess the safety and tolerability of a drug, rather than its efficacy in treating a particular condition
One unexpected serious adverse reaction occurred in a NAC-treated patient caused by an erroneous iv infusion rate (1.5g-loading dose-15 min followed by 7.5 g delivered over 3h15min instead of 4 h), causing chest tightness, despite stable vital signs, which was resolved by corticosteroids and discontinuation of iv NAC
Discover causes and targeted relief Recognizing severe acid reflux GLP-1 meds slow stomach emptying, causing prolonged acid reflux
60 servings Formula with HPMC plant-based envelope Halal-certified and athlete-tested Take 2 capsules a day with a full glass of water, ideally with a meal
such formulation has addressed the issues with low oral bioavailability of luteolin [278]